Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDAC
{{output}}
Objectives: To investigate the proteomic profile of different molecular subtypes of pancreatic ductal adenocarcinoma (PDAC) and understand their impact on patient outcomes, particularly focusing on pathways involved in xenobiotic... ...